Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $26.52 USD
Change Today -0.38 / -1.41%
Volume 282.1K
QDEL On Other Exchanges
As of 8:10 PM 03/26/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John D. Tamerius Ph.D.

Senior Vice President of Clinical & Regulatory Affairs, Quidel Corp.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

As of Fiscal Year 2013


Dr. John D. Tamerius, Ph.D., has been Senior Vice President of Clinical & Regulatory Affairs at Quidel Corp. since November 10, 2008. Dr. Tamerius co-founded Cytotech, Inc. He has been an integral part of Quidel for 25 years. He served as Vice President of Clinical/Regulatory Affairs at Quidel Corp. from June 2005 to November 2008. He previously held a variety of executive roles including responsibility for research and development and general management of Northern ...

Read Full Background

Corporate Headquarters*

12544 High Bluff Drive
San Diego, California 92130

United States

Phone: 858-552-1100
Fax: 858-453-4338

Board Members Memberships*

There is no Board Members Memberships data available.


University of Washington
University of Washington
University of Washington

Other Affiliations*

Annual Compensation*

Total Annual Compensation$297,544

Stock Options*

Restricted Stock Awards$152,584
All Other Compensation$107,011
Exercised Options28,852
Exercised Options Value$449,404
Exercisable Options167,220
Exercisable Options Value$2,384,364
Unexercisable Options74,397
Unexercisable Options Value$800,850
Total Value of Options$3,634,617
Total Number of Options270,469

Total Compensation*

Total Annual Cash Compensation$488,242
Total Short Term Compensation$297,544
Other Long Term Compensation$259,595
Total Calculated Compensation$820,818
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
QDEL:US $26.52 USD -0.38


James W. Green Chief Executive Officer, President and Director
Analogic Corporation
John A. Kraeutler Chairman of The Board, Chief Executive Officer and President
Meridian Bioscience, Inc.
Nachum Shamir Chief Executive Officer and President
Luminex Corporation
Douglas A. Michels Chief Executive Officer, President and Director
OraSure Technologies, Inc.
Olivier Legrain Chief Executive Officer, President, Director and Member of Nomination Committee
Ion Beam Applications, S.A.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact QUIDEL CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at